Neuromuscular junction dysfunctions due to immune checkpoint inhibitors therapy: An analysis of FAERS data in the past 15 years

INTRODUCTION: The adverse effects of neuromuscular junction dysfunctions caused by immune checkpoint inhibitor (ICI) drugs have not been thoroughly assessed in the clinics. OBJECTIVE: To assess the neuromuscular junction dysfunctions in cancer patients with adverse events caused by ICI therapy by se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Lao, Donghui, Chen, Haoyan, Zhao, Bin, Du, Qiong, Zhai, Qing, Ye, Xuan, Yu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446345/
https://www.ncbi.nlm.nih.gov/pubmed/36081514
http://dx.doi.org/10.3389/fimmu.2022.778635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446345/
https://www.ncbi.nlm.nih.gov/pubmed/36081514
http://dx.doi.org/10.3389/fimmu.2022.778635

Ejemplares similares